$CRM
Salesforce, Inc.

2020 Q3 Form 10-Q Financial Statement

#000110852420000041 Filed on August 28, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $5.151B $3.997B
YoY Change 28.87% 21.82%
Cost Of Revenue $1.311B $967.0M
YoY Change 35.57% 13.9%
Gross Profit $3.840B $3.030B
YoY Change 26.73% 24.59%
Gross Profit Margin 74.55% 75.81%
Selling, General & Admin $2.764B $2.199B
YoY Change 25.69% 18.61%
% of Gross Profit 71.98% 72.57%
Research & Development $898.0M $607.0M
YoY Change 47.94% 31.1%
% of Gross Profit 23.39% 20.03%
Depreciation & Amortization $649.0M $457.0M
YoY Change 42.01% 81.35%
% of Gross Profit 16.9% 15.08%
Operating Expenses $3.662B $2.972B
YoY Change 23.22% 28.27%
Operating Profit $178.0M $58.00M
YoY Change 206.9% -49.57%
Interest Expense $676.0M $106.0M
YoY Change 537.74% 171.79%
% of Operating Profit 379.78% 182.76%
Other Income/Expense, Net -$21.00M -$3.000M
YoY Change 600.0% -88.89%
Pretax Income $839.0M $164.0M
YoY Change 411.59% -29.0%
Income Tax -$1.786B $73.00M
% Of Pretax Income -212.87% 44.51%
Net Earnings $2.625B $91.00M
YoY Change 2784.62% -69.57%
Net Earnings / Revenue 50.96% 2.28%
Basic Earnings Per Share $2.90 $0.12
Diluted Earnings Per Share $2.85 $0.11
COMMON SHARES
Basic Shares Outstanding 904.0M shares 776.0M shares
Diluted Shares Outstanding 922.0M shares 795.0M shares

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.283B $6.042B
YoY Change 53.64% 76.31%
Cash & Equivalents $4.052B $3.510B
Short-Term Investments $5.231B $2.532B
Other Short-Term Assets $1.170B $743.0M
YoY Change 57.47% 8.15%
Inventory
Prepaid Expenses
Receivables $3.445B $2.332B
Other Receivables $0.00 $0.00
Total Short-Term Assets $14.85B $9.903B
YoY Change 49.91% 45.59%
LONG-TERM ASSETS
Property, Plant & Equipment $2.528B $2.283B
YoY Change 10.73% 14.95%
Goodwill $26.30B $13.20B
YoY Change 99.27% 7.71%
Intangibles $4.676B $1.725B
YoY Change 171.07% -12.7%
Long-Term Investments $2.555B $1.614B
YoY Change 58.3% 34.28%
Other Assets $2.580B $603.0M
YoY Change 327.86% 31.37%
Total Long-Term Assets $42.93B $23.43B
YoY Change 83.22% 23.2%
TOTAL ASSETS
Total Short-Term Assets $14.85B $9.903B
Total Long-Term Assets $42.93B $23.43B
Total Assets $57.78B $33.34B
YoY Change 73.33% 29.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.485B $2.271B
YoY Change 53.46% 1029.85%
Accrued Expenses $767.0M $706.0M
YoY Change 8.64% -27.74%
Deferred Revenue $8.711B $7.142B
YoY Change 21.97% 21.4%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.000M $4.000M
YoY Change -25.0% -99.2%
Total Short-Term Liabilities $12.96B $10.20B
YoY Change 27.15% 20.38%
LONG-TERM LIABILITIES
Long-Term Debt $2.673B $2.973B
YoY Change -10.09% -6.3%
Other Long-Term Liabilities $1.297B $661.0M
YoY Change 96.22% 1.23%
Total Long-Term Liabilities $3.970B $3.634B
YoY Change 9.25% -5.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.96B $10.20B
Total Long-Term Liabilities $3.970B $3.634B
Total Liabilities $19.34B $16.17B
YoY Change 19.6% 31.52%
SHAREHOLDERS EQUITY
Retained Earnings $4.585B $2.218B
YoY Change 106.72% 74.78%
Common Stock $33.92B $15.03B
YoY Change 125.78% 22.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.44B $17.17B
YoY Change
Total Liabilities & Shareholders Equity $57.78B $33.34B
YoY Change 73.33% 29.09%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $2.625B $91.00M
YoY Change 2784.62% -69.57%
Depreciation, Depletion And Amortization $649.0M $457.0M
YoY Change 42.01% 81.35%
Cash From Operating Activities $429.0M $436.0M
YoY Change -1.61% -4.8%
INVESTING ACTIVITIES
Capital Expenditures $114.0M $178.0M
YoY Change -35.96% 4.71%
Acquisitions $1.154B $423.0M
YoY Change 172.81% -91.19%
Other Investing Activities -$2.479B -$674.0M
YoY Change 267.8% -84.99%
Cash From Investing Activities -$2.593B -$852.0M
YoY Change 204.34% -81.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $441.0M -$183.0M
YoY Change -340.98% -131.07%
NET CHANGE
Cash From Operating Activities $429.0M $436.0M
Cash From Investing Activities -$2.593B -$852.0M
Cash From Financing Activities $441.0M -$183.0M
Net Change In Cash -$1.720B -$600.0M
YoY Change 186.67% -83.35%
FREE CASH FLOW
Cash From Operating Activities $429.0M $436.0M
Capital Expenditures $114.0M $178.0M
Free Cash Flow $315.0M $258.0M
YoY Change 22.09% -10.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001108524
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32224
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3997000000 USD
dei Entity Registrant Name
EntityRegistrantName
salesforce.com, inc.
dei Entity Address Address Line1
EntityAddressAddressLine1
Salesforce Tower
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3320693
dei Entity Address Address Line2
EntityAddressAddressLine2
415 Mission Street, 3rd Fl
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94105
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
901-7000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
CRM
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
910000000 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4052000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4145000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
5231000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3802000000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3445000000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6174000000 USD
CY2020Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
948000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
926000000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1170000000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
916000000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
14846000000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
15963000000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2528000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2375000000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2985000000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3040000000 USD
CY2020Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1309000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1348000000 USD
CY2020Q3 us-gaap Other Long Term Investments
OtherLongTermInvestments
2555000000 USD
CY2020Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
1963000000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
26301000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
25134000000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4676000000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4724000000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2580000000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
579000000 USD
CY2020Q3 us-gaap Assets
Assets
57780000000 USD
CY2020Q1 us-gaap Assets
Assets
55126000000 USD
CY2020Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3485000000 USD
CY2020Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3433000000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
767000000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
750000000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8711000000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10662000000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12963000000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14845000000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2407000000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2445000000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1297000000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1278000000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
19340000000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
21241000000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
1000000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
1000000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33922000000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32116000000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-68000000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-93000000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4585000000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1861000000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
38440000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
33885000000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57780000000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55126000000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5151000000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3997000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10016000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7734000000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1311000000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
967000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2565000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1881000000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
3840000000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
3030000000 USD
us-gaap Gross Profit
GrossProfit
7451000000 USD
us-gaap Gross Profit
GrossProfit
5853000000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
898000000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
607000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1757000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1161000000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2275000000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1824000000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4665000000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3521000000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
489000000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
375000000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
991000000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
737000000 USD
CY2020Q3 crm Fair Value Adjustment Loss On Remaining Performance Obligationsof Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsofAgreements
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
605000000 USD
CY2019Q3 crm Fair Value Adjustment Loss On Remaining Performance Obligationsof Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsofAgreements
166000000 USD
crm Fair Value Adjustment Loss On Remaining Performance Obligationsof Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsofAgreements
0 USD
crm Fair Value Adjustment Loss On Remaining Performance Obligationsof Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsofAgreements
166000000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
3662000000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
2972000000 USD
us-gaap Operating Expenses
OperatingExpenses
7413000000 USD
us-gaap Operating Expenses
OperatingExpenses
5585000000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
178000000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
58000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
38000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
268000000 USD
CY2020Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
682000000 USD
CY2019Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
109000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
874000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
390000000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12000000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
839000000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
164000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
886000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
646000000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1786000000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1838000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
163000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2625000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
91000000 USD
us-gaap Net Income Loss
NetIncomeLoss
2724000000 USD
us-gaap Net Income Loss
NetIncomeLoss
483000000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.90
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.85
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
904000000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
776000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
901000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
774000000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
922000000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
795000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
919000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
795000000 shares
CY2020Q3 us-gaap Income Tax Reconciliation Disposition Of Assets
IncomeTaxReconciliationDispositionOfAssets
-2000000000.0 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2625000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
91000000 USD
us-gaap Net Income Loss
NetIncomeLoss
2724000000 USD
us-gaap Net Income Loss
NetIncomeLoss
483000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
28000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-17000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
5000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-30000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
49000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
6000000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
24000000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
14000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
77000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-11000000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
29000000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-16000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
10000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1000000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
4000000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
3000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
67000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
25000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-19000000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2692000000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
79000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2749000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
464000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
33885000000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
119000000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
504000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-42000000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
99000000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
34565000000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
578000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
67000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2625000000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
38440000000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
15605000000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
113000000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
343000000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7000000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
392000000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
16446000000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
253000000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
388000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
91000000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
17166000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2625000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
91000000 USD
us-gaap Net Income Loss
NetIncomeLoss
483000000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
649000000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
457000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1307000000 USD
us-gaap Net Income Loss
NetIncomeLoss
2724000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
894000000 USD
CY2020Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
250000000 USD
CY2019Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
217000000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
497000000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
426000000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
578000000 USD
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
388000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1082000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
731000000 USD
CY2020Q3 crm Fair Value Adjustment Loss On Remaining Performance Obligationsof Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsofAgreements
0 USD
CY2019Q3 crm Fair Value Adjustment Loss On Remaining Performance Obligationsof Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsofAgreements
166000000 USD
crm Fair Value Adjustment Loss On Remaining Performance Obligationsof Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsofAgreements
0 USD
crm Fair Value Adjustment Loss On Remaining Performance Obligationsof Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsofAgreements
166000000 USD
CY2020Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
682000000 USD
CY2019Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
109000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
874000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
390000000 USD
CY2020Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2003000000 USD
CY2019Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2003000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
349000000 USD
CY2019Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
146000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2745000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2628000000 USD
CY2020Q3 crm Increase Decreasein Capitalized Contract Costs
IncreaseDecreaseinCapitalizedContractCosts
455000000 USD
CY2019Q3 crm Increase Decreasein Capitalized Contract Costs
IncreaseDecreaseinCapitalizedContractCosts
173000000 USD
crm Increase Decreasein Capitalized Contract Costs
IncreaseDecreaseinCapitalizedContractCosts
480000000 USD
crm Increase Decreasein Capitalized Contract Costs
IncreaseDecreaseinCapitalizedContractCosts
297000000 USD
CY2020Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
203000000 USD
CY2019Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-28000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
214000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
69000000 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
693000000 USD
CY2019Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
293000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-64000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-252000000 USD
CY2020Q3 crm Increase Decreasein Operating Lease Liabilities
IncreaseDecreaseinOperatingLeaseLiabilities
-209000000 USD
CY2019Q3 crm Increase Decreasein Operating Lease Liabilities
IncreaseDecreaseinOperatingLeaseLiabilities
-182000000 USD
crm Increase Decreasein Operating Lease Liabilities
IncreaseDecreaseinOperatingLeaseLiabilities
-412000000 USD
crm Increase Decreasein Operating Lease Liabilities
IncreaseDecreaseinOperatingLeaseLiabilities
-346000000 USD
CY2020Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-465000000 USD
CY2019Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-594000000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2020000000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1573000000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
429000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2288000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2401000000 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
436000000 USD
CY2020Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1154000000 USD
CY2019Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
423000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1257000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
433000000 USD
CY2020Q3 crm Payments For Investments In Privately Held Companies
PaymentsForInvestmentsInPrivatelyHeldCompanies
232000000 USD
CY2019Q3 crm Payments For Investments In Privately Held Companies
PaymentsForInvestmentsInPrivatelyHeldCompanies
62000000 USD
crm Payments For Investments In Privately Held Companies
PaymentsForInvestmentsInPrivatelyHeldCompanies
574000000 USD
crm Payments For Investments In Privately Held Companies
PaymentsForInvestmentsInPrivatelyHeldCompanies
221000000 USD
CY2020Q3 crm Proceeds From Investments In Privately Held Companies
ProceedsFromInvestmentsInPrivatelyHeldCompanies
51000000 USD
CY2019Q3 crm Proceeds From Investments In Privately Held Companies
ProceedsFromInvestmentsInPrivatelyHeldCompanies
71000000 USD
crm Proceeds From Investments In Privately Held Companies
ProceedsFromInvestmentsInPrivatelyHeldCompanies
652000000 USD
crm Proceeds From Investments In Privately Held Companies
ProceedsFromInvestmentsInPrivatelyHeldCompanies
265000000 USD
CY2020Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1681000000 USD
CY2019Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
772000000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2515000000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1506000000 USD
CY2020Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
207000000 USD
CY2019Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
375000000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
544000000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
461000000 USD
CY2020Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
330000000 USD
CY2019Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
137000000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
557000000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
193000000 USD
CY2020Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
114000000 USD
CY2019Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
178000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
437000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
337000000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2593000000 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-852000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3030000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1578000000 USD
CY2020Q3 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
466000000 USD
CY2019Q3 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
152000000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
724000000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
371000000 USD
CY2020Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
24000000 USD
CY2019Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
134000000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
72000000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
145000000 USD
CY2020Q3 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1000000 USD
CY2019Q3 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
201000000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
2000000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
202000000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
441000000 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-183000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
650000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24000000 USD
CY2020Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3000000 USD
CY2019Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6000000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1720000000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-600000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-93000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
841000000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5772000000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4110000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4145000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2669000000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4052000000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3510000000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4052000000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3510000000 USD
CY2020Q3 us-gaap Interest Paid Net
InterestPaidNet
2000000 USD
CY2019Q3 us-gaap Interest Paid Net
InterestPaidNet
6000000 USD
us-gaap Interest Paid Net
InterestPaidNet
48000000 USD
us-gaap Interest Paid Net
InterestPaidNet
56000000 USD
CY2020Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
66000000 USD
CY2019Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
37000000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
124000000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
55000000 USD
CY2020Q3 crm Equity Awards Assumed
EquityAwardsAssumed
6000000 USD
CY2019Q3 crm Equity Awards Assumed
EquityAwardsAssumed
0 USD
crm Equity Awards Assumed
EquityAwardsAssumed
6000000 USD
crm Equity Awards Assumed
EquityAwardsAssumed
0 USD
us-gaap Fiscal Period
FiscalPeriod
<div style="text-indent:24.75pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Fiscal Year</span></div><div style="text-indent:24.75pt;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s fiscal year ends on January 31. References to fiscal 2021, for example, refer to the fiscal year ending January 31, 2021.</span></div>
CY2020Q3 crm Number Of Publicly Traded Investments Held
NumberOfPubliclyTradedInvestmentsHeld
1 investment
CY2020Q3 crm Percent Of Total Strategic Investments Publicly Traded
PercentOfTotalStrategicInvestmentsPubliclyTraded
0.30
CY2020Q3 crm Number Of Investments Held
NumberOfInvestmentsHeld
3 investment
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:24.75pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:24.75pt;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the Company’s condensed consolidated financial statements and notes thereto.</span></div><div style="text-indent:24.75pt;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Significant estimates and assumptions made by management include the determination of:</span></div><div style="text-indent:-13.5pt;padding-left:40.5pt;margin-top:3.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">•</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt;">the fair value of assets acquired and liabilities assumed for business combinations;</span></div><div style="text-indent:-13.5pt;padding-left:40.5pt;margin-top:3.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">•</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt;">the standalone selling price (“SSP”) of performance obligations for revenue contracts with multiple performance obligations;</span></div><div style="text-indent:-13.5pt;padding-left:40.5pt;margin-top:3.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">•</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt;">the valuation of privately-held strategic investments, including impairments;</span></div><div style="text-indent:-13.5pt;padding-left:40.5pt;margin-top:3.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">•</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt;">the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions;</span></div><div style="text-indent:-13.5pt;padding-left:40.5pt;margin-top:3.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">•</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt;">the average period of benefit associated with costs capitalized to obtain revenue contracts; </span></div><div style="text-indent:-13.5pt;padding-left:40.5pt;margin-top:3.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">•</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt;">the useful lives of intangible assets; and</span></div><div style="text-indent:-13.5pt;padding-left:40.5pt;margin-top:3.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">•</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt;">the fair value of certain stock awards issued.</span></div><div style="text-indent:24.75pt;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the result of which forms the basis for making judgments about the carrying values of assets and liabilities. </span></div><div style="text-indent:24.75pt;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the novel coronavirus and resulting disease (“COVID-19”) was reported and in March 2020 the World Health Organization declared it a pandemic. The extent of the impact of COVID-19 on the Company’s operational and financial performance will depend on certain developments, including the duration of the outbreak, impact on the Company’s </span></div>customers and its sales and renewal cycles, and impact on the Company’s employees, as discussed in more detail in Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. These estimates may change, as new events occur and additional information is obtained, and such changes will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from these estimates and any such differences may be material to the Company’s financial statements.
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-indent:24.75pt;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Concentrations of Credit Risk, Significant Customers and Investments</span></div><div style="text-indent:24.75pt;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable. Collateral is not required for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable due to estimated credit losses. This allowance is based upon historical loss patterns, the number of days that billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts and current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss patterns. The Company records the allowance against bad debt expense through the condensed consolidated statement of operations up to the amount of revenues recognized to date. Any incremental allowance is recorded as an offset to unearned revenue on the condensed consolidated balance sheet. Receivables are written-off and charged against the recorded allowance when the Company has exhausted collection efforts without success. </span></div><div style="text-indent:24.75pt;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">No single customer accounted for more than five percent of accounts receivable at July 31, 2020 and January 31, 2020. No single customer accounted for five percent or more of total revenue during the six months ended July 31, 2020 and 2019. As of July 31, 2020 and January 31, 2020, assets located outside the Americas were 15 percent and 12 percent of total assets, respectively. As of July 31, 2020 and January 31, 2020, assets located in the United States were 83 percent and 87 percent of total assets, respectively.</span></div><div style="text-indent:24.75pt;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is also exposed to concentrations of risk in its strategic investment portfolio. As of July 31, 2020, the Company held one publicly traded investment with a carrying value greater than 30 percent of its total strategic investments. In addition, the Company held three investments with carrying values that were individually greater than five percent of its total strategic investments, all of which were privately held. As of January 31, 2020, the Company held five investments that were individually greater than five percent of its total strategic investments, of which one was publicly traded and four were privately held. The publicly traded investment held as of July 31, 2020 is different than the publicly traded investment that was held as of January 31, 2020.</span></div>
CY2020Q1 crm Number Of Investments Held
NumberOfInvestmentsHeld
5 investment
CY2020Q1 crm Percent Of Total Strategic Investments Privately Held
PercentOfTotalStrategicInvestmentsPrivatelyHeld
0.05
CY2020Q1 crm Percent Of Total Strategic Investments
PercentOfTotalStrategicInvestments
0.05
CY2020Q1 crm Number Of Publicly Traded Investments Held
NumberOfPubliclyTradedInvestmentsHeld
1 investment
CY2020Q1 crm Number Of Privately Held Investments
NumberOfPrivatelyHeldInvestments
4 investment
CY2020Q3 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P4Y
crm Capitalized Contract Cost Renewalsand Success Fees Amortization Term
CapitalizedContractCostRenewalsandSuccessFeesAmortizationTerm
P2Y
crm Increase Decreasein Capitalized Contract Costs
IncreaseDecreaseinCapitalizedContractCosts
480000000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
497000000 USD
crm Increase Decreasein Capitalized Contract Costs
IncreaseDecreaseinCapitalizedContractCosts
297000000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
426000000 USD
CY2020Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
2300000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
2300000000 USD
crm Impairments Of Costs To Obtain Revenue Contracts
ImpairmentsOfCostsToObtainRevenueContracts
0 USD
CY2019Q3 crm Impairments Of Costs To Obtain Revenue Contracts
ImpairmentsOfCostsToObtainRevenueContracts
0 USD
CY2020Q3 crm Impairments Of Costs To Obtain Revenue Contracts
ImpairmentsOfCostsToObtainRevenueContracts
0 USD
crm Impairments Of Costs To Obtain Revenue Contracts
ImpairmentsOfCostsToObtainRevenueContracts
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
crm Sharebased Compensation Arrangementby Sharebased Payment Award Award Offering Period
SharebasedCompensationArrangementbySharebasedPaymentAwardAwardOfferingPeriod
P12M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.15
crm Sharebased Compensation Arrangementby Sharebased Payment Award Purchase Period
SharebasedCompensationArrangementbySharebasedPaymentAwardPurchasePeriod
P6M
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5151000000 USD
crm Percentageof Tax Benefit Likely To Be Realized Upon Settlement
PercentageofTaxBenefitLikelyToBeRealizedUponSettlement
0.50
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10016000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7734000000 USD
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
508000000 USD
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
449000000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9112000000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7585000000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10662000000 USD
CY2019Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8564000000 USD
CY2020Q3 crm Contractwith Customer Liability Billingsand Other
ContractwithCustomerLiabilityBillingsandOther
4632000000 USD
CY2019Q3 crm Contractwith Customer Liability Billingsand Other
ContractwithCustomerLiabilityBillingsandOther
3396000000 USD
crm Contractwith Customer Liability Billingsand Other
ContractwithCustomerLiabilityBillingsandOther
7937000000 USD
crm Contractwith Customer Liability Billingsand Other
ContractwithCustomerLiabilityBillingsandOther
6110000000 USD
CY2020Q3 crm Contractwith Customer Liability Contributionfrom Contract Asset
ContractwithCustomerLiabilityContributionfromContractAsset
54000000 USD
CY2019Q3 crm Contractwith Customer Liability Contributionfrom Contract Asset
ContractwithCustomerLiabilityContributionfromContractAsset
7000000 USD
crm Contractwith Customer Liability Contributionfrom Contract Asset
ContractwithCustomerLiabilityContributionfromContractAsset
59000000 USD
crm Contractwith Customer Liability Contributionfrom Contract Asset
ContractwithCustomerLiabilityContributionfromContractAsset
51000000 USD
CY2020Q3 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
64000000 USD
CY2019Q3 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
151000000 USD
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
69000000 USD
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
151000000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8711000000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7142000000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8711000000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7142000000 USD
CY2020Q3 crm Revenue Remaining Performance Obligation Current
RevenueRemainingPerformanceObligationCurrent
15200000000 USD
CY2020Q3 crm Revenue Remaining Performance Obligation Noncurrent
RevenueRemainingPerformanceObligationNoncurrent
15400000000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
30600000000 USD
CY2020Q1 crm Revenue Remaining Performance Obligation Current
RevenueRemainingPerformanceObligationCurrent
15000000000.0 USD
CY2020Q1 crm Revenue Remaining Performance Obligation Noncurrent
RevenueRemainingPerformanceObligationNoncurrent
15800000000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
30800000000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5188000000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
46000000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5231000000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3789000000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3802000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1990000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1332000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
3233000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2466000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
8000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
4000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5231000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3802000000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
829000000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
3000000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
829000000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
3000000 USD
crm Unrealized Losses On Fixed Rate Investments Upper Range Value
UnrealizedLossesOnFixedRateInvestmentsUpperRangeValue
1000000 USD
CY2019Q3 us-gaap Investment Income Net
InvestmentIncomeNet
31000000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
47000000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
57000000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
18000000 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
31000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
46000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
57000000 USD
CY2020Q3 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1000000 USD
CY2019Q3 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1000000 USD
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
2000000 USD
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1000000 USD
CY2020Q3 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
0 USD
CY2019Q3 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
1000000 USD
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
1000000 USD
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
1000000 USD
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
19000000 USD
crm Equity Securitieswithout Readily Determinable Fair Value Impairment Lossand Downward Price Adjustment Annual Amount
EquitySecuritieswithoutReadilyDeterminableFairValueImpairmentLossandDownwardPriceAdjustmentAnnualAmount
76000000 USD
crm Equity Securitieswithout Readily Determinable Fair Value Impairment Lossand Downward Price Adjustment Annual Amount
EquitySecuritieswithoutReadilyDeterminableFairValueImpairmentLossandDownwardPriceAdjustmentAnnualAmount
51000000 USD
CY2020Q3 us-gaap Other Long Term Investments
OtherLongTermInvestments
2555000000 USD
CY2020Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
1963000000 USD
CY2020Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1731000000 USD
CY2019Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
927000000 USD
CY2020Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1502000000 USD
CY2019Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
785000000 USD
CY2020Q3 crm Strategic Investments Net Additions Reductions
StrategicInvestmentsNetAdditionsReductions
-209000000 USD
CY2019Q3 crm Strategic Investments Net Additions Reductions
StrategicInvestmentsNetAdditionsReductions
-9000000 USD
crm Strategic Investments Net Additions Reductions
StrategicInvestmentsNetAdditionsReductions
56000000 USD
crm Strategic Investments Net Additions Reductions
StrategicInvestmentsNetAdditionsReductions
11000000 USD
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
25000000 USD
CY2019Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
32000000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
55000000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
172000000 USD
CY2020Q3 crm Equity Securitieswithout Readily Determinable Fair Value Impairment Lossand Downward Price Adjustment Annual Amount
EquitySecuritieswithoutReadilyDeterminableFairValueImpairmentLossandDownwardPriceAdjustmentAnnualAmount
10000000 USD
CY2019Q3 crm Equity Securitieswithout Readily Determinable Fair Value Impairment Lossand Downward Price Adjustment Annual Amount
EquitySecuritieswithoutReadilyDeterminableFairValueImpairmentLossandDownwardPriceAdjustmentAnnualAmount
33000000 USD
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1537000000 USD
CY2019Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
917000000 USD
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1537000000 USD
CY2019Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
917000000 USD
CY2020Q3 crm Equity Securitieswithout Readily Determinable Fair Value Impairment Lossand Downward Price Adjustment Cumulative Amount
EquitySecuritieswithoutReadilyDeterminableFairValueImpairmentLossandDownwardPriceAdjustmentCumulativeAmount
178000000 USD
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
509000000 USD
CY2020Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
682000000 USD
CY2019Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
109000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
874000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
390000000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
168000000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
527000000 USD
CY2020Q3 crm Number Of Publicly Traded Investments Sold
NumberOfPubliclyTradedInvestmentsSold
2 employee
CY2020Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-633000000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-586000000 USD
CY2020Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
14000000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
91000000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
864000000 USD
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
8174000000 USD
CY2020Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
94000000 USD
CY2020Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
370000000 USD
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
6239000000 USD
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
24000000 USD
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
24000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6922000000 USD
crm Finitelived Intangible Assets Additionsand Retirements Net
FinitelivedIntangibleAssetsAdditionsandRetirementsNet
507000000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7429000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2198000000 USD
crm Finitelived Intangible Assets Amortization Expenseand Retirements Net
FinitelivedIntangibleAssetsAmortizationExpenseandRetirementsNet
555000000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2753000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4724000000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4676000000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y6M
CY2020Q3 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
284000000 USD
CY2019Q3 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
127000000 USD
us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
555000000 USD
us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
256000000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
568000000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1076000000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
921000000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
833000000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
568000000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
4000000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
48.50
CY2020Q3 crm Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
710000000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4676000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
25134000000 USD
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
69000000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
26301000000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2676000000 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2677000000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3000000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1182000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2020Q3 crm Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1500000000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
2692000000 USD
CY2020Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
24000000 USD
CY2019Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
28000000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
48000000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
56000000 USD
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1000000 USD
CY2019Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1000000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2000000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2000000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
25000000 USD
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
29000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
50000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
58000000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
150000000 USD
CY2020Q3 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1300000000 USD
CY2020Q1 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1500000000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
40.06
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
38.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
40.69
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27000000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
98.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
8000000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
143.56
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6000000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
75.67
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
136.90
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
28000000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
115.05
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2183000000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
25000000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
112.45
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2073000000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
11000000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
79.70
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1312000000 USD
CY2020Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
28000000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y
CY2020Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
115.05
CY2020Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
11000000 shares
CY2020Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
79.70
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000000 USD
CY2020Q3 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
6000000 USD
CY2020Q3 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Remainingof Fiscal Year
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationRemainingofFiscalYear
1115000000 USD
CY2020Q3 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Year Two
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationYearTwo
1759000000 USD
CY2020Q3 crm Share Based Compensation Arrangement By Share Based Payment Award Amortization Year One
ShareBasedCompensationArrangementByShareBasedPaymentAwardAmortizationYearOne
1273000000 USD
CY2020Q3 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Year Three
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationYearThree
690000000 USD
CY2020Q3 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Year Four
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationYearFour
114000000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4951000000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2020Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
148000000 shares
CY2020Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
133000000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1800000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
886000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-2.07
CY2020Q3 us-gaap Income Tax Reconciliation Disposition Of Assets
IncomeTaxReconciliationDispositionOfAssets
-2000000000.0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
163000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
646000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2625000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
91000000 USD
us-gaap Net Income Loss
NetIncomeLoss
2724000000 USD
us-gaap Net Income Loss
NetIncomeLoss
483000000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
904000000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
776000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
901000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
774000000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
18000000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
19000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
18000000 shares
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
24000000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
21000000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
922000000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
795000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
919000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
795000000 shares
CY2020Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
crm Lessee Operating Lease Termination Period
LesseeOperatingLeaseTerminationPeriod
P1Y
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
258000000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
217000000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
537000000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
423000000 USD
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
224000000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
450000000 USD
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
177000000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
366000000 USD
CY2020Q3 crm Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
1066000000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.026
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P20Y
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.044
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
435000000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
11000000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
736000000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
23000000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
555000000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
23000000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
398000000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
24000000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
307000000 USD
CY2020Q3 crm Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
410000000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3497000000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
515000000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
323000000 USD
CY2020Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
177000000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3174000000 USD
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
338000000 USD
CY2020Q3 crm Lessor Operating Lease Payments To Be Received Next Five Years
LessorOperatingLeasePaymentsToBeReceivedNextFiveYears
179000000 USD
CY2020Q3 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
44000000 USD
CY2020Q3 crm Lessee Operating Lease Lease Notyet Commenced Amount
LesseeOperatingLeaseLeaseNotyetCommencedAmount
2400000000 USD
CY2020Q3 crm Lessee Operating Lease Commitmentincluding Lease Notyet Commenced Amount
LesseeOperatingLeaseCommitmentincludingLeaseNotyetCommencedAmount
5900000000 USD

Files In Submission

Name View Source Status
0001108524-20-000041-index-headers.html Edgar Link pending
0001108524-20-000041-index.html Edgar Link pending
0001108524-20-000041.txt Edgar Link pending
0001108524-20-000041-xbrl.zip Edgar Link pending
crm-20200731.htm Edgar Link pending
crm-20200731.xsd Edgar Link pending
crm-20200731_cal.xml Edgar Link unprocessable
crm-20200731_def.xml Edgar Link unprocessable
crm-20200731_g1.jpg Edgar Link pending
crm-20200731_g2.jpg Edgar Link pending
crm-20200731_g3.jpg Edgar Link pending
crm-20200731_g4.jpg Edgar Link pending
crm-20200731_htm.xml Edgar Link completed
crm-20200731_lab.xml Edgar Link unprocessable
crm-20200731_pre.xml Edgar Link unprocessable
ex311-ceocertq2fy21.htm Edgar Link pending
ex312-cfocertq2fy21.htm Edgar Link pending
ex321-soxcertsq2fy21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending